Press Releases May 28, 2026 04:15 PM

Acuity to Announce Fiscal 2026 Third-Quarter Results on June 25, 2026

Acuity Inc. Scheduled to Report Fiscal 2026 Q3 Earnings on June 25, 2026

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
AYI

Acuity Inc., a leading industrial technology company specializing in lighting and intelligent space solutions, will announce its fiscal 2026 third-quarter earnings on June 25, 2026, followed by a conference call led by CEO Neil Ashe. The company operates through two key segments: Acuity Brands Lighting and Acuity Intelligent Spaces, providing innovative products to enhance customer outcomes globally.

Acuity to Announce Fiscal 2026 Third-Quarter Results on June 25, 2026
AYI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Acuity Inc. will release its fiscal Q3 2026 results on June 25, 2026, including a webcast and conference call.
  • The company operates in industrial technology focusing on lighting, lighting controls, building management, and audio-video control platforms.
  • Acuity Inc. pursues growth through innovation, expanding market share, and entering new verticals internationally.

ATLANTA, May 28, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) (the “Company”) will release fiscal 2026 third-quarter results on Thursday, June 25, 2026 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call.

The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company's website at www.investors.acuityinc.com on Thursday, June 25, 2026. The online replay will remain available for a limited time following the call. A replay of the call will also be posted to the Investor Relations site two hours after the completion of the conference call and will be archived on the website.

To learn more about Acuity, please visit the Company's website.

About Acuity

Acuity Inc. (NYSE: AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people’s lives.

We achieve growth through the development of innovative new products and services, including lighting, lighting controls, building management solutions, and an audio, video and control platform. We focus on customer outcomes and drive growth and productivity to increase market share and deliver superior returns. We look to aggressively deploy capital to grow the business and to enter attractive new verticals.

Acuity Inc. is based in Atlanta, Georgia, with operations across North America, Europe and Asia. The Company is powered by approximately 13,000 dedicated and talented associates. Visit us at www.acuityinc.com.

Investor Contact:
Charlotte McLaughlin
Vice President, Investor Relations
(404) 853-1456
investor.relations@acuityinc.com

Media Contact:
April Appling
Senior Vice President, Corporate Marketing and Communications
corporatecommunications@acuityinc.com


Risks

  • Uncertainty around the upcoming earnings results impacting investor sentiment and stock price volatility.
  • Potential challenges in executing growth strategies or new product developments could affect future performance.
  • Exposure to global market conditions given operations across North America, Europe, and Asia may introduce economic and geopolitical risks.

More from Press Releases

onsemi Introduces Industry-First Elite Pairing Studio to Simplify Power Design Jun 8, 2026 Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle Jun 8, 2026 Rackspace Technology Establishes Regional Headquarters in Riyadh to Accelerate Cloud and AI Growth Jun 8, 2026 WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace Jun 8, 2026 Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology Jun 8, 2026